Exhibiting at the Oncology Convention


Moovcare by SIVAN is the first digital therapeutic in oncology that was approved for reimbursement in France.
Moovcare® application creates a new reality in lung cancer follow-up, the product was clinically proven to extend life of lung cancer patients, improves quality of life and saves time for physicians.
Moovcare enables better communication between oncologists and patients, reduce workload and emergency hospitalizations.
Moovcare It's a medical device class I and needs to be subscribed by an oncologist.
Moovcare is deployed in many hospitals in France and soon in UK.

Visit Website


Exhibitor product 1Exhibitor product 2Exhibitor product 3